We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00472147
Recruitment Status : Unknown
Verified May 2007 by Charite University, Berlin, Germany.
Recruitment status was:  Not yet recruiting
First Posted : May 11, 2007
Last Update Posted : May 11, 2007
Sponsor:
Information provided by:

Study Description
Brief Summary:
Sudden cardiac death is the most frequent cause of death in industrialized countries. The most efficient interventiont in ventricular fibrillation is defibrillation in an appropriate timely manner. But since the intervention of defibrillation the optimal shock energy is unknown. As a too low energy is not able to terminate ventricular fibrillation a too high energy may cause asystole wich jeopardizes survival itself. We study the efficacy of different shock energies on the termination of ventricular fibrillatiion and survival.

Condition or disease Intervention/treatment
Sudden Cardiac Death Arrhythmia Survival Procedure: shock efficacy

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Shock
U.S. FDA Resources

Arms and Interventions


Outcome Measures

Primary Outcome Measures :
  1. termination of vf survival

Secondary Outcome Measures :
  1. resulting rhythm CPC score

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • out of hospital sudden cardiac death
  • ventricular fibrillation

Exclusion Criteria:

  • non cardiac death
  • asystole
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00472147


Contacts
Contact: Dirk Müller, MD, PhD +49 30 8445 ext 3554 dr.dirk.mueller@charite.de
Contact: Hans-Richard Arntz, MD, PhD +49 30 8445 ext 2640 hans-richard.arntz@charite.de

Locations
Germany
Charité campus Benjamin Franklin
Berlin, Germany, 12200
Sponsors and Collaborators
Charite University, Berlin, Germany
Investigators
Principal Investigator: Dirk Müller, MD, PhD Charite University, Berlin, Germany
More Information

ClinicalTrials.gov Identifier: NCT00472147     History of Changes
Other Study ID Numbers: CBF-2007002
First Posted: May 11, 2007    Key Record Dates
Last Update Posted: May 11, 2007
Last Verified: May 2007

Additional relevant MeSH terms:
Death
Out-of-Hospital Cardiac Arrest
Death, Sudden, Cardiac
Pathologic Processes
Heart Arrest
Heart Diseases
Cardiovascular Diseases
Death, Sudden